共 95 条
[1]
van Hoogstraten HJF(1999)Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis J Hepatol 31 256-262
[2]
Hansen BE(1996)Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 610-615
[3]
van Buuren HR(2000)Impact of fatigue on the quality of life of patients with primary biliary cirrhosis Am J Gastroenterol 95 760-767
[4]
ten Kate FJW(1985)Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis Gastroenterology 88 108-114
[5]
van Berge Henegouwen GP(1998)Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses J Hepatol 29 417-423
[6]
Schalm SW(1961)An inventory for measuring depression Arch Gen Psychiatry 6 561-571
[7]
Broome U(1994)Measuring the functional impact of fatigue: initial validation of the fatigue impact scale Clin Infect Dis 18 Suppl 1 S79-83
[8]
Olsson R(1998)Fatigue and radiotherapy: (A) experience in patients undergoing treatment Br J Cancer 78 899-906
[9]
Loof L(2000)Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use J Hepatol 32 368-373
[10]
Bodemar G(1992)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 473-483